.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Merck
Fish and Richardson
Baxter
Federal Trade Commission
McKesson
Citi
Cipla
Cantor Fitzgerald

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070202

« Back to Dashboard
NDA 070202 describes LORAZ, which is a drug marketed by Quantum Pharmics, Hospira, Leading Pharma Llc, Lupin Ltd, Watson Labs, Sagent Agila Llc, Akorn, Amneal Pharms, Am Therap, Halsey, Watson Labs Inc, Warner Chilcott, Usl Pharma, Sandoz, Paddock Llc, Sun Pharm Inds Ltd, Superpharm, Roxane, Intl Medication Sys, Anda Repository, Vintage Pharms, Mylan, Pharm Assoc, Hi-tech Pharma Co, Mutual Pharm, Par Pharm, Bedford, Dava Pharms Inc, West-ward Pharms Int, Ani Pharms Inc, and Bedford Labs, and is included in seventy NDAs. Additional details are available on the LORAZ profile page.

The generic ingredient in LORAZ is lorazepam. There are eleven drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for 070202

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 070202

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG
Approval Date:Aug 9, 1985TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Express Scripts
Accenture
Boehringer Ingelheim
Deloitte
Merck
Cantor Fitzgerald
Federal Trade Commission
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot